Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
(高级)医药代表 /(资深)产品专员 Chuzhou (Anhui Province) China International Innovative Medicines Sales Jun 06, 2024
(高级)医药代表 /(资深)产品专员 Chuzhou (Anhui Province) China International Innovative Medicines Sales Jun 06, 2024
(高级)医药代表 /(资深)产品专员 Shantou (Guangdong Province) China International Innovative Medicines Sales Jun 06, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North Remote USA US Innovative Medicines Research & Development Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
District Manager Changsha (Hunan Province) China International Innovative Medicines Sales Jun 05, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jun 05, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Sourcing Manager R&D, Drug Development Hyderabad (Office) India Operations CTS Procurement Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Jun 04, 2024
Enterprise Architecture and Integration Director for Commercial Areas INSURGENTES Mexico Operations CTS Technology Transformation Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
县域主任/县域主管 Luoyang (Henan Province) China International Innovative Medicines Sales Jun 04, 2024
Change Control Coordinator Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jun 03, 2024
Analyst Hyderabad (Office) India Operations CTS Marketing Jun 02, 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development Jun 02, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others May 31, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development May 30, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development May 30, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) India Operations CTS Technology Transformation May 29, 2024
(高级)医药代表 /(资深)产品专员 Guangzhou (Guangdong Province) China International Innovative Medicines Sales May 29, 2024
Senior Specialist, Master Batch Record (MBR) Design Indianapolis USA Operations CTS Technology Transformation May 28, 2024
Therapeutic Area Biomarker Lead Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 28, 2024
Equipment Operator Stein Aargau Switzerland Operations Innovative Medicines Technical Operations May 28, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 28, 2024
SMR Fuzhou (Fujian Province) China International Innovative Medicines Sales May 28, 2024
Senior Molecular Imaging Expert (Senior Principal Scientist) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 27, 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development May 27, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 23, 2024
Senior Analyst - Data & Products Hyderabad (Office) India Operations CTS Marketing May 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia